Meeting
2021 ASCO Annual Meeting
Correlation of HRD status with clinical and survival outcomes in patients with advanced-stage ovarian cancer.
Authors
Travis T. Sims
The University of Texas MD Anderson Cancer Center, Houston, TX
Travis T. Sims , Anil K. Sood , Shannon Neville Westin , Bryan M. Fellman , Jenna Unke , Kelly M Rangel , Tyler Hilton , Nicole D. Fleming
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 5568)
DOI
10.1200/JCO.2021.39.15_suppl.5568
Abstract #
5568
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
BRCA1 and RAD51 methylation impact on outcome in patients with advanced ovarian cancer: A PAOLA-1 ancillary study.
First Author: Helene Blons
Poster
2023 ASCO Annual Meeting
The role of Chemotherapy Response Score (CRS) in the decision making process for advanced high grade serous ovarian cancer patients undergoing neoadjuvant chemotherapy.
First Author: Claudia Marchetti
Poster
2023 ASCO Annual Meeting
Utility of surgically documented minimal residual disease as a therapeutic target and early surrogate of frontline treatment outcomes in ovarian cancer.
First Author: Anne Knisely
Poster
2021 ASCO Annual Meeting
Does aggressive surgery only benefit patients with less advanced ovarian cancer?
First Author: Shinichi Tate